Pacific Biosciences of California, Inc. (PACB) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

Pacific Biosciences of California, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

Pacific Biosciences of California, Inc. (PACB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $9.85 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-25

• Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $9.85M, a 6.47% decline from fiscal 2024.
• Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $10.53M, a 79.90% increase from fiscal 2023.
• Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $5.85M.